EKR Therapeutics has appointed Robert Roche Jr as an independent director to its Board.
John Bailye, President and CEO of EKR Therapeutics, said that Mr Roche “brings a wealth of operating and management experience to our company at a time when we are working hard to expand our business”.
Mr. Roche currently works as Independent Director of NuPathe in Conshohocken, Pennsylvania. His previous positions include executive vice president of Worldwide Pharmaceutical Operations at Cephalon as well as various sales and marketing roles at SmithKline Beecham.
EKR Therapeutics is a pharmaceutical company that provides acute care products to the hospital marketplace.